Quantitative analysis of sea urchin egg kinesin-driven microtubule motility.
We have analyzed the effects of various substrates and inhibitors on the rates of microtubule (MT) motility induced by sea urchin egg kinesin using real-time computer analysis and video-enhanced light microscopy. In the presence of magnesium, 10 mM concentrations of all the nucleotides tested supported MT translocation, with velocities in MgATP greater than MgGTP greater than MgTTP approximately equal to MgUTP greater than MgCTP greater than MgITP. The velocity of kinesin-driven MT motility is fairly uniform over approximately 3 pH units, from pH 6 to 9, with almost no motility outside this range. In the presence of ATP, no motility is observed in the absence of divalent cations; addition of Mg2+ but not addition of Ca2+ restores motility. MgATP-dependent MT motility is reversibly inhibited by Mg-free ATP, EDTA, or tripolyphosphate, suggesting that Mg-free ATP is an inactive substrate analogue. MgATP and MgGTP both obey saturable, Michaelis-Menten kinetics, with apparent Km values of approximately 60 microM and 2 mM, and Vmax values of approximately 0.6 and 0.4 microns/s, respectively. MgATP gamma S and MgADP are classic competitive inhibitors of kinesin-driven motility in MgATP, with Ki values of approximately 15 and 150 microM, respectively. Adenosine 5'-(beta, gamma-methylene)-triphosphate and N-ethylmaleimide only inhibit MT motility weakly, while adenyl-5'-yl imidodiphosphate and vanadate strongly inhibit MT motility, but not in a simple competitive manner. Moreover, in contrast to other inhibitors which cause a unimodal decrease in MT mean velocity, vanadate concentrations greater than approximately 10% that of MgATP cause some MTs to become immotile, resulting in a bimodal distribution of MT velocities.
Cohn
S A
SA
National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.
Ingold
A L
AL
Scholey
J M
JM
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000251:Adenosine Triphosphatases; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000266:Adenylyl Imidodiphosphate / Q000494:pharmacology; D000818:Animals; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D016547:Kinesins; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D008868:Microtubule Proteins; D008870:Microtubules / Q000502:physiology*; D009068:Movement / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000502:physiology*; D009711:Nucleotides / Q000494:pharmacology; D010063:Ovum / Q000648:ultrastructure*; D012617:Sea Urchins
D008868:Microtubule Proteins; D009419:Nerve Tissue Proteins; D009711:Nucleotides; D000266:Adenylyl Imidodiphosphate; C036852:magnesium GTP; C005147:5'-adenylyl (beta,gamma-methylene)diphosphonate; C022571:adenosine 5'-O-(3-thiotriphosphate); D000244:Adenosine Diphosphate; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; D016547:Kinesins; D008274:Magnesium; C002630:alpha,beta-methyleneadenosine 5'-triphosphate; D005033:Ethylmaleimide